Emisphere oral diabetic treatment shows promise
The study evaluated the safety and efficacy of low and high fixed doses of oral insulin tablets versus placebo in patients with type 2 diabetes mellitus on existing
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.